Prognostic Value of the Preoperative Lymphocyte-C-Reactive Protein Ratio in Hepatocellular Carcinoma Patients Treated with Curative Intent: A Large-Scale Multicentre Study
Yong-Fa Zhang,1,2,* Liang-He Lu,3,4,* Chong Zhong,5,* Min-Shan Chen,3,4 Rong-Ping Guo,3,4 Lu Wang1,2 1Department of Hepatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China; 2Department of Oncology, Shanghai Medical College, Fudan University, Shanghai,...
Guardado en:
Autores principales: | Zhang YF, Lu LH, Zhong C, Chen MS, Guo RP, Wang L |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/40e80e449876498f98497bc1f712a2f1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Efficacy of radiofrequency ablation versus laparoscopic liver resection for hepatocellular carcinoma in China:
a comprehensive meta-analysis
por: Zhijun Li, et al.
Publicado: (2021) -
Early experience with laparoscopic treatment of liver tumors using a separable cluster electrode with a no-touch technique
por: Hyun Hong, et al.
Publicado: (2020) -
Amphiregulin as a novel diagnostic and prognostic biomarker of hepatocellular carcinoma before and after locoregional treatment
por: Amira Isaac, et al.
Publicado: (2021) -
Transcatheter chemoembolization plus percutaneous radiofrequency ablation versus laparoscopic radiofrequency ablation: improved outcome for inoperable hepatocellular carcinoma
por: Bin Chai, et al.
Publicado: (2021) -
Combination therapy with PD-1 blockade and radiofrequency ablation for recurrent hepatocellular carcinoma: a propensity score matching analysis
por: Xiaofei Wang, et al.
Publicado: (2021)